Skip to main content
. 2022 May 6;17:2069–2078. doi: 10.2147/IJN.S362418

Figure 4.

Figure 4

The in vitro uptake ability and cytotoxicity of Lec and Lec(RSV) nanoparticles. (A and B) The BT474 breast cancer cells uptake of Lec and Lec(RSV) encapsulated FITC; (C) in vitro cytotoxicity assay to observe the cancer cell killing ability of Lec, RSV, and Lec(RSV), respectively; (D) ROS scavenging effects of Lec, RSV and Lec(RSV). ***Indicated significance value of p < 0.001; compared to control.